KospicyKorean filings in English
Filings / DSK Co.,Ltd.

Beneficial Ownership Report (5%) — Standard Form

DSK Co.,Ltd. · 주식등의대량보유상황보고서(일반)

SC 13D/GKOSDAQ · 109740 Filed 2026-11-19Korean original on DART

English form view 62% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on large shareholdings (general)

6.1

(주)디에스케이

0000

Report on Large Holdings of Shares, etc.

(General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control)
To: Financial Services CommissionReporting obligation date:2026-11-12
To: Korea ExchangeReport reference date:2026-11-19
Reporting person:(주)시너지이노베이션
Summary
Issuer name(주)디에스케이Relationship to IssuerLargest Shareholder
Report TypeChange
Number of Shares Held and Holding RatioNumber of Shares HeldHolding Ratio
Previous Report11,075,44043.08
Current Report11,075,44043.08
Shares under key agreements: number and ratioNumber of shares, etc.Ratio
Previous Report11,075,44043.08
Current Report11,075,44043.08
Number of voting rights and holding ratioNumber of Voting RightsHolding Ratio
Previous Report--
Current Report--
Voting rights under key agreements: number and ratioNumber of Voting RightsRatio
Previous Report--
Current Report--
Reason for Report주식매매계약 관련 잔금 미지급에 따른 계약내용 변경
※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission.

Part 1 Report Overview

1. Issuer information

Company Name(주)디에스케이Company code109740
Entity typeKOSDAQ-Listed CompanyTotal Issued Voting Shares (shares)25,710,390

2. Major shareholder information

a. Reporting person

(1) Reporting person overview

Report TypeChangeJoint signatories
Reporting person typeDomestic corporationNationalityRepublic of Korea
Basis for Reporter Classification (only if reported as a statutory partnership or other entity)-
Name (Entity Name)Korean(주)시너지이노베이션Chinese characters (English)Synergy Innovation Co., Ltd.
Address (Head Office) [Town/District Level Only]경기도 성남시 중원구 사기막골로Date of Birth or Business Registration No., etc.120-81-79246
Occupation (business)의료기기 제조업Relationship to IssuerLargest Shareholder
Business contact and person in chargeAffiliated company(주)시너지이노베이션DepartmentManagement Support Team
PositionDeputy General ManagerPhone Number02-219**
Name김영민Fax number031-74**
Email address**synergyinno.com

(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)

(Unit: KRW m)
Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)336,885Total Liabilities64,492
Total Equity272,394Paid-in Capital44,053
Representative (representative or managing partner)박진형
Decision-Making Body (Decision Maker)Board of Directors
Largest Shareholder (Largest Investor)에스이노베이션신기술조합Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)35.85

※ 2025년말 연결재무제표 기준입니다.
보고자의 최대주주가 법인, 기타단체, 법령상조합, 민법상 조합의 경우】- 에스이노베이션 신기술조합

(Unit: KRW m)
Legal form법령상 조합
Total Assets (or Total Assets Under Management)74,078Total Liabilities-
Total Equity74,078Paid-in Capital82,765
Representative (representative or managing partner)시너지아이비투자(주)
Decision-Making Body (Decision Maker)조합원 총회
Largest Shareholder (Largest Investor)시너지파트너스(주)Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)55.7

※ 2025년말 재무제표 기준입니다.

b. Specially related parties

(1) Specially related party overview

No.NameCategorySpecific Relationship to ReporterDate of Birth or Business Registration No., etc.NationalityAddress (Location)Occupation (Business)Relationship to Issuer
1시너지바이오조합기타단체(국내)조합원236-80-00805Republic of Korea서울특별시 서초구 강남대로Investment businessShareholder
2김태구Individual (Domestic)Officer of Affiliate590723Republic of Korea경기도 용인시 기흥구 석현로경영자Executive officers (registered)
* Address to town/district level only

(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)

- 시너지바이오조합

(Unit: KRW m)
Legal form민법상 조합
Total Assets (or Total Assets Under Management)9,982Total Liabilities-
Total Equity9,982Paid-in Capital22,500
Representative (representative or managing partner)김종원
Decision-Making Body (Decision Maker)조합원 총회
Largest Shareholder (Largest Investor)(주)시너지이노베이션Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)44.4

※ 2025년말 재무제표 기준입니다.

c. Collective investment manager

(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))

(1) Collective investment manager overview

No.NameBusiness Registration No., etc.Target collective investment vehicleNationalityAddress (Location)Remarks
-------

(2) Collective investment manager details

Legal form-
Paid-in Capital-Total Assets Under Management-
Representative-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Corporate Representative)-Largest Shareholder Stake-

3. Shares, etc. held and holding ratio

Report reference dateReporting personShares, etc.Share CertificatesTotal Issued Voting Shares (shares)
Name of HolderNumber of Specially Related PersonsNumber of Shares, etc. (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report2026-10-08(주)시너지이노베이션311,075,44043.0811,075,44043.0825,710,390
This Report2026-11-19(주)시너지이노베이션311,075,44043.0811,075,44043.0825,710,390
Change00000

4. Purpose of holding

Impact on management control
보고자와 특별관계자는 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각호에 대한 사항에 대하여 영향력을 행사하고 있습니다. 회사의 업무집행과 관련한 주요사항이 발생할 경우에는 관계법령 등에서 허용하는 범위 및 방법에 따라 회사의 경영목적 부합하는 의사결정을 할 예정입니다.※ 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항1. 임원의 선임ㆍ해임 또는 직무의 정지2. 이사회 등 「상법」에 따른 회사의 기관과 관련된 정관의 변경3. 회사의 자본금의 변경4. 삭제 <2020. 1. 29.>5. 회사의 합병, 분할과 분할합병6. 주식의 포괄적 교환과 이전7. 영업전부의 양수ㆍ양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수ㆍ양도8. 자산 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분9. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익 전부를 같이하는 계약, 그 밖에 이에 준하는 계약의 체결, 변경 또는 해약10. 회사의 해산

5. Reason for change

Method of change-
Reason for change-
Reason for Change주식매매계약 관련 잔금 미지급에 따른 계약내용 변경

Part 2 Details of Large Holdings

1. Holdings by reporting person and specially related persons

A. Holdings by type of shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Shares Held
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person(주)시너지이노베이션120-81-792466,425,432--------6,425,43224.99
Specially Related Party시너지바이오조합236-80-008052,161,834--------2,161,8348.41
김태구5907232,488,174--------2,488,1749.68
Aa1a2BCDEFG
H
Total Issued Voting Shares (I)Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H)Holding Ratio (%)
Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100Share Holding Ratio (A / I) × 100
25,710,390-43.0843.08

※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares

B. Holdings by form of holding

RelationshipName (Entity Name)Date of Birth or Business Registration No., etc.Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act)Total
No. 1No. 2No. 3No. 4No. 5No. 6No. 7Number of sharesRatio
Reporting person(주)시너지이노베이션120-81-792466,425,432------6,425,43224.99
Specially Related Party시너지바이오조합236-80-008052,161,834------2,161,8348.41
김태구5907232,488,174------2,488,1749.68
※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them

[조합원 출자 내역]

특별관계자(조합원) 성명출자비율(%)
㈜시너지이노베이션44.4
㈜태광19.5
강진용11.1
㈜대신인터내셔날4.4
윤성덕4.4
심상칠4.4
구정회4.4
㈜대신3.6
문화숙2.2
최경란1.3
김종원0.1

2. Contracts on shares held

A. Contract status

Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.)
Yes

*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported

B. Contract details

No.Name (Entity Name)Relationship to ReporterDate of Birth or Business Registration No., etc.Type of shares, etc.Number of shares, etc.CounterpartyContract typeContract date (amendment date)Contract periodRatioRemarks
1(주)시너지이노베이션Self120-81-79246Voting Shares4,768,808윤진파트너스(주),제이점와이(J.Y)1호투자조합주식매매계약2026.11.122025.08.06~2026.11.3018.55Note)
2(주)시너지이노베이션Self120-81-79246Voting Shares828,312(주)지브로파트너스주식매매계약2026.11.122025.08.06~2026.11.303.22Note)
3(주)시너지이노베이션Self120-81-79246Voting Shares828,312(주)더블유에이치파트너스주식매매계약2026.11.122025.08.06~2026.11.303.22Note)
4시너지바이오조합Related party236-80-00805Voting Shares2,161,834윤진파트너스(주),제이점와이(J.Y)1호투자조합주식매매계약2026.11.122025.08.06~2026.11.308.41Note)
5김태구Related party590723Voting Shares1,244,087원마인드1호조합주식매매계약2026.11.122025.08.06~2026.11.304.84Note)
6김태구Related party590723Voting Shares1,244,087씨앤케이6조합주식매매계약2026.11.122025.08.06~2026.11.304.84Note)
Total (number of shares, etc.)11,075,440Total (ratio)43.08Note)

주1) (주)시너지이노베이션, 시너지바이오조합, 김태구는 상기와 같은 내용으로 윤진파트너스(주)외 5인과 발행회사에 대한 주식매매계약을 체결하였습니다.주2) 주식 및 경영권양수도계약 주요일정- 계약체결일: 2025.08.06- 1차 변경계약체결일: 2025.09.25- 2차 변경계약체결일: 2025.11.13- 3차 변경계약체결일: 2026.03.31- 4차 잔금일 연기 합의일(공문 통지 및 확인서 회신): 2026.06.15- 5차 변경계약체결일: 2026.06.29- 6차 변경계약체결일: 2026.07.28- 7차 변경계약체결일: 2026.08.04- 8차 변경계약체결일: 2026.09.30- 변경잔금지급일: 2026.11.12 (매수인 잔금 미지급)- 최종 거래종결기한: 2026.11.30주3) 잔금은 거래종결의 선행조건(*)이 모두 충족되는 것을 전제로, 매도인이 발행회사의 주식을 이전하고 매수인이 잔금을 지급하는 거래종결 시점에 지급되는 금액을 의미합니다. 매도인은 잔금 전액 수령 즉시 대상주식의 소유권을 매수인 명의 증권계좌로 이전하고, 본 계약 및 관련 합의서상 의무를 이행할 예정입니다.[(*) '프로톡스'에서 식약처에 기 제출한 보툴리눔 톡신 품목허가 관련 조건 및 디에스케이 임시주주총회 소집 개최 등 거래종결을 위한 절차 및 조건이 모두 충족되는 경우]당사는 2026-09-30 체결한 추가계약에 따라 잔금 지급기한을 2026-11-12로 변경하였으나, 동 기한까지 매수인 측이 잔금을 지급하지 아니하여 매수인의 귀책사유에 따른 계약해제 사유가 발생하였습니다.본 거래의 최종 거래종결기한은 2026-11-30이며, 향후 계약해제 여부 등 본 거래와 관련한 주요 사항이 결정되거나 변동사항이 발생하는 경우 관련 법령 및 규정에 따라 지체 없이 공시할 예정입니다. 상기 계약 관련 세부사항은 당사가 2026-11-12 제출한 주요사항보고서(타법인 주식 및 출자증권 양도결정) 정정공시 내용을 참조하시기 바랍니다.

C. Additional details if the main contract is a security agreement

No.Number of shares, etc.Loan amountDebtorInterest rateCollateral maintenance ratioOther
-------

3. Holdings by proprietary and customer account (financial institutions only)

NameRelationship to ReporterBy accountTotal
Own Account (shares)Ratio (%)Customer account (shares)Ratio (%)Total (shares)Ratio (%)
--------
Total------

Part 3 Material Changes Since Last Report Date

1. Summary of changes

a. Changes in shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Changes in Shares, etc.
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person(주)시너지이노베이션120-81-79246-----------
Specially Related Party시너지바이오조합236-80-00805-----------
김태구590723-----------

2. Change details

a. Detailed changes in shares, etc.

(Unit: shares, KRW)
Name (Entity Name)Date of Birth or Business Registration No., etc.Change Date*Acquisition/disposal methodType of shares, etc.Change detailsAcquisition/disposal unit price**Remarks
Before ChangeChangeAfter Change
-----------

* For trades on the securities market, the contract date

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities

3. Source of acquisition funds

(1) Overview of acquisition funds

(Unit: KRW)
NameDate of birth or business registration no., etc.Own funds (H)Borrowings (I)Other (J)Total (H+I+J)
------

(2) Origin and source of acquisition funds